{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:03:27Z","timestamp":1769760207784,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Various literatures have demonstrated that overexpression of Metadherin (MTDH) is correlated with tumor metastasis and it can predict poor survival outcomes in female reproduction malignancies. In order to enhance the statistical power and reach a recognized conclusion, we conducted a systematic review and meta-analysis to thoroughly investigate the association of MTDH expression with tumor metastasis and survival outcomes following PRISMA guidelines. Odds ratios (ORs) and hazard ratios (HRs) were used to demonstrate the impact of MTDH on tumor metastasis and prognosis respectively. Data were pooled with appropriate effects model on STATA12.0. Our results indicated that high MTDH expression is significantly correlated with higher mortality for breast, ovarian and cervical cancer. High immunohistochemical expression of MTDH is remarkably associated with shorter disease-free survival (DFS) in breast cancer but not in ovarian cancer. The pooled results suggested that high level of MTDH significantly predicted distant metastasis and lymph node metastasis in breast cancer. Strong associations were observed between MTDH expression and lymph node metastasis in ovarian and cervical cancer. In conclusion, MTDH might be a novel biomarker which can effectively reflect metastasis status and prognosis of breast cancer. However, its application in clinical practice needs more prospective studies with large samples.<\/jats:p>","DOI":"10.1038\/srep38365","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T10:36:34Z","timestamp":1480934194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of MTDH immunohistochemical expression with metastasis and prognosis in female reproduction malignancies: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"6","author":[{"given":"Yongbin","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghua","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"BFsrep38365_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J Clin."},{"key":"BFsrep38365_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J Clin. 66, 115\u2013132 (2016).","journal-title":"CA Cancer J Clin."},{"key":"BFsrep38365_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1535-6108(04)00079-0","volume":"5","author":"DM Brown","year":"2004","unstructured":"Brown, D. M. et al. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell. 5, 365\u2013374 (2004).","journal-title":"Cancer Cell."},{"key":"BFsrep38365_CR4","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1038\/sj.onc.1205445","volume":"21","author":"ZZ Su","year":"2002","unstructured":"Su, Z. Z. et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 21, 3592\u20133602 (2002).","journal-title":"Oncogene."},{"key":"BFsrep38365_CR5","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1078-0432.CCR-07-4054","volume":"14","author":"J Li","year":"2008","unstructured":"Li, J. et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res. 14, 3319\u20133326 (2008).","journal-title":"Clin Cancer Res"},{"key":"BFsrep38365_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PGP.0b013e3181ffd2f7","volume":"30","author":"F Meng","year":"2011","unstructured":"Meng, F. et al. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. Int J Gynecol Pathol. 30, 145\u2013150 (2011).","journal-title":"Int J Gynecol Pathol"},{"key":"BFsrep38365_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1477-7819-11-297","volume":"11","author":"K Huang","year":"2013","unstructured":"Huang, K. et al. High expression of astrocyte elevated gene-1 (AEG-1) is associated with progression of cervical intraepithelial neoplasia and unfavorable prognosis in cervical cancer. World J Surg Oncol. 11, 297 (2013).","journal-title":"World J Surg Oncol"},{"key":"BFsrep38365_CR8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/IGC.0b013e3181ef8e21","volume":"20","author":"H Song","year":"2010","unstructured":"Song, H. et al. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer. 20, 1188\u20131196 (2010).","journal-title":"Int J Gynecol Cancer"},{"key":"BFsrep38365_CR9","doi-asserted-by":"crossref","first-page":"e0145659","DOI":"10.1371\/journal.pone.0145659","volume":"10","author":"Y Luo","year":"2015","unstructured":"Luo, Y. et al. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients. PLoS One. 10, e0145659 (2015).","journal-title":"PLoS One."},{"key":"BFsrep38365_CR10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.trsl.2015.05.004","volume":"166","author":"C Yang","year":"2015","unstructured":"Yang, C. et al. Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis. Transl Res. 166, 614\u2013626 e612 (2015).","journal-title":"Transl Res."},{"key":"BFsrep38365_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-401676-7.00004-8","volume":"120","author":"L Wan","year":"2013","unstructured":"Wan, L. et al. Pleiotropic roles of AEG-1\/MTDH\/LYRIC in breast cancer. Adv Cancer Res. 120, 113\u2013134 (2013).","journal-title":"Adv Cancer Res"},{"key":"BFsrep38365_CR12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.canlet.2014.11.050","volume":"357","author":"P Liu","year":"2015","unstructured":"Liu, P. et al. miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer. Cancer Lett. 357, 384\u2013392 (2015).","journal-title":"Cancer Lett."},{"key":"BFsrep38365_CR13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/onc.2012.128","volume":"32","author":"A Ward","year":"2013","unstructured":"Ward, A. et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene. 32, 1173\u20131182 (2013).","journal-title":"Oncogene."},{"key":"BFsrep38365_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2008.11.013","volume":"15","author":"G Hu","year":"2009","unstructured":"Hu, G. et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 15, 9\u201320 (2009).","journal-title":"Cancer Cell."},{"key":"BFsrep38365_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1746-1596-5-38","volume":"5","author":"P Su","year":"2010","unstructured":"Su, P. et al. Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagn Pathol. 5, 38 (2010).","journal-title":"Diagn Pathol"},{"key":"BFsrep38365_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jso.21788","volume":"103","author":"C Li","year":"2011","unstructured":"Li, C. et al. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol. 103, 184\u2013192 (2011).","journal-title":"J Surg Oncol"},{"key":"BFsrep38365_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IGC.0b013e3182145561","volume":"21","author":"C Li","year":"2011","unstructured":"Li, C. et al. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Int J Gynecol Cancer. 21, 602\u2013608 (2011).","journal-title":"Int J Gynecol Cancer"},{"key":"BFsrep38365_CR18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2559.2012.04182.x","volume":"60","author":"C Li","year":"2012","unstructured":"Li, C. et al. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Histopathology. 60, 953\u2013963 (2012).","journal-title":"Histopathology."},{"key":"BFsrep38365_CR19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3892\/or.2013.2598","volume":"30","author":"M Long","year":"2013","unstructured":"Long, M. et al. Overexpression of astrocyte-elevated gene-1 is associated with cervical carcinoma progression and angiogenesis. Oncol Rep. 30, 1414\u20131422 (2013).","journal-title":"Oncol Rep."},{"key":"BFsrep38365_CR20","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.18632\/oncotarget.2522","volume":"5","author":"R Dong","year":"2014","unstructured":"Dong, R. et al. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Oncotarget. 5, 10816\u201310829 (2014).","journal-title":"Oncotarget"},{"key":"BFsrep38365_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1186\/1471-2407-14-869","volume":"14","author":"C Du","year":"2014","unstructured":"Du, C. et al. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFkappaB-dependent pathway. BMC Cancer. 14, 869 (2014).","journal-title":"BMC Cancer."},{"key":"BFsrep38365_CR22","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s13277-013-1400-0","volume":"35","author":"C Li","year":"2014","unstructured":"Li, C. et al. Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors. Tumour Biol. 35, 3079\u20133085 (2014).","journal-title":"Tumour Biol."},{"key":"BFsrep38365_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12282-012-0398-2","volume":"21","author":"E Tokunaga","year":"2014","unstructured":"Tokunaga, E. et al. Overexpression of metadherin\/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer. 21, 341\u2013349 (2014).","journal-title":"Breast Cancer"},{"key":"BFsrep38365_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/IGC.0000000000000381","volume":"25","author":"E Song","year":"2015","unstructured":"Song, E. et al. Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling. Int J Gynecol Cancer. 25, 345\u2013355 (2015).","journal-title":"Int J Gynecol Cancer"},{"key":"BFsrep38365_CR25","first-page":"827","volume":"37","author":"L Tan","year":"2015","unstructured":"Tan, L. et al. [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer]. Zhonghua Zhong Liu Za Zhi. 37, 827\u2013832 (2015).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"BFsrep38365_CR26","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.3892\/mmr.2014.3056","volume":"11","author":"B Zhou","year":"2015","unstructured":"Zhou, B. et al. Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression. Mol Med Rep. 11, 2981\u20132990 (2015).","journal-title":"Mol Med Rep"},{"key":"BFsrep38365_CR27","first-page":"2385","volume":"9","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Onco Targets Ther. 9, 2385\u20132392 (2016).","journal-title":"Onco Targets Ther"},{"key":"BFsrep38365_CR28","first-page":"133","volume":"34","author":"P Jin","year":"2013","unstructured":"Jin, P. et al. Expression of metadherin gene in metastatic breast cancer and its clinical significance. Academic Journal of Pla Postgraduate Medical School. 34, 133\u2013136 (2013).","journal-title":"Academic Journal of Pla Postgraduate Medical School"},{"key":"BFsrep38365_CR29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. et al. Quantifying heterogeneity in a meta-analysis. Stat Med. 21, 1539\u20131558 (2002).","journal-title":"Stat Med."},{"key":"BFsrep38365_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/B978-0-12-401676-7.00005-X","volume":"120","author":"X Meng","year":"2013","unstructured":"Meng, X. et al. Drug resistance mediated by AEG-1\/MTDH\/LYRIC. Adv Cancer Res. 120, 135\u2013157 (2013).","journal-title":"Adv Cancer Res"},{"key":"BFsrep38365_CR31","doi-asserted-by":"crossref","first-page":"e20920","DOI":"10.1371\/journal.pone.0020920","volume":"6","author":"X Meng","year":"2011","unstructured":"Meng, X. et al. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS One. 6, e20920 (2011).","journal-title":"PLoS One."},{"key":"BFsrep38365_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4161\/cbt.13.1.18868","volume":"13","author":"X Kong","year":"2012","unstructured":"Kong, X. et al. Inhibition of metadherin sensitizes breast cancer cells to AZD6244. Cancer Biol Ther. 13, 43\u201349 (2012).","journal-title":"Cancer Biol Ther"},{"key":"BFsrep38365_CR33","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1074\/jbc.M112.395913","volume":"288","author":"N Zhang","year":"2013","unstructured":"Zhang, N. et al. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer. J Biol Chem. 288, 9396\u20139407 (2013).","journal-title":"J Biol Chem"},{"key":"BFsrep38365_CR34","first-page":"1520","volume":"27","author":"Y Zhao","year":"2012","unstructured":"Zhao, Y. et al. Metadherin regulates radioresistance in cervical cancer cells. Oncol Rep. 27, 1520\u20131526 (2012).","journal-title":"Oncol Rep."},{"key":"BFsrep38365_CR35","first-page":"3546","volume":"124","author":"X Zhang","year":"2011","unstructured":"Zhang, X. et al. Astrocyte elevated gene-1 induces breast cancer proliferation and invasion through upregulating HER2\/neu expression. Chin Med J (Engl). 124, 3546\u20133550 (2011).","journal-title":"Chin Med J (Engl)"},{"key":"BFsrep38365_CR36","doi-asserted-by":"crossref","first-page":"e29363","DOI":"10.1371\/journal.pone.0029363","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One. 6, e29363 (2011).","journal-title":"PLoS One."},{"key":"BFsrep38365_CR37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/sj.onc.1210713","volume":"27","author":"SG Lee","year":"2008","unstructured":"Lee, S. G. et al. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene. 27, 1114\u20131121 (2008).","journal-title":"Oncogene."},{"key":"BFsrep38365_CR38","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1074\/jbc.C111.291518","volume":"287","author":"X Meng","year":"2012","unstructured":"Meng, X. et al. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. J Biol Chem. 287, 4485\u20134491 (2012).","journal-title":"J Biol Chem"},{"key":"BFsrep38365_CR39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ccr.2014.04.027","volume":"26","author":"L Wan","year":"2014","unstructured":"Wan, L. et al. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell. 26, 92\u2013105 (2014).","journal-title":"Cancer Cell."},{"key":"BFsrep38365_CR40","doi-asserted-by":"crossref","first-page":"22243","DOI":"10.1073\/pnas.1009479107","volume":"107","author":"SK Bhutia","year":"2010","unstructured":"Bhutia, S. K. et al. Astrocyte elevated gene-1 induces protective autophagy. Proc Natl Acad Sci USA. 107, 22243\u201322248 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep38365_CR41","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s13277-013-0794-z","volume":"34","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK\/NF-kappaB pathway. Tumour Biol. 34, 2433\u20132440 (2013).","journal-title":"Tumour Biol."},{"key":"BFsrep38365_CR42","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/ncomms7658","volume":"6","author":"RK Krishnan","year":"2015","unstructured":"Krishnan, R. K. et al. Quantitative analysis of the TNF-alpha-induced phosphoproteome reveals AEG-1\/MTDH\/LYRIC as an IKKbeta substrate. Nat Commun. 6, 6658 (2015).","journal-title":"Nat Commun."},{"key":"BFsrep38365_CR43","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1159\/000358719","volume":"33","author":"C Xu","year":"2014","unstructured":"Xu, C. et al. MTDH mediates estrogen-independent growth and tamoxifen resistance by down-regulating PTEN in MCF-7 breast cancer cells. Cell Physiol Biochem. 33, 1557\u20131567 (2014).","journal-title":"Cell Physiol Biochem"},{"key":"BFsrep38365_CR44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney, J. F. et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 8, 16 (2007).","journal-title":"Trials."},{"key":"BFsrep38365_CR45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian, R. et al. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 45, 139\u2013145 (2015).","journal-title":"Contemp Clin Trials"},{"key":"BFsrep38365_CR46","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel, N. et al. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22, 719\u2013748 (1959).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep38365_CR47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P. et al. Measuring inconsistency in meta-analyses. BMJ. 327, 557\u2013560 (2003).","journal-title":"BMJ."},{"key":"BFsrep38365_CR48","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 339, b2700 (2009).","journal-title":"BMJ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38365","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:52:08Z","timestamp":1672879928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38365"],"URL":"https:\/\/doi.org\/10.1038\/srep38365","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]},"assertion":[{"value":"21 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38365"}}